A review of the scientific evidence for biofilms in wounds

Wound Repair and Regeneration

Volumn 20, Issue 5, 2012, Pages 647-657

  Percival, Steven L ^a   Hill, Katja E ^b   Williams, David W ^b   Hooper, Samuel J ^b   Thomas, Dave W ^b   Costerton, John W ^c  

^a Scapa Polymerics Limited   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN; PROTEINASE; PSEUDOMONIC ACID;

BIOFILM; CHRONIC WOUND; ENZYME ACTIVITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MEDICAL LITERATURE; MICROBIAL IDENTIFICATION; MICROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; REVIEW; TISSUE CULTURE; TISSUE ENGINEERING; WOUND DRESSING; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANTI-INFECTIVE AGENTS; BIOFILMS; CHRONIC DISEASE; DIABETIC FOOT; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; IODINE; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SILVER SULFADIAZINE; VARICOSE ULCER; WOUND HEALING; WOUND INFECTION;

EID: 84866516167     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00836.x     Document Type: Review

References (124)

1. Walker JT, Verran J, Boyle B, Percival SL,. Microscopy methods to investigate the structure of potable water biofilms. Methods Enzymol 2002; 337: 243-255.
2. Walker JT, Percival SL,. Control of biofouling in drinking water systems. In:, Walker JT, Surman S, Jess J, editors. Industrial biofouling: detection, prevention and control, vol. 1. Chichester, UK.: John Wiley and Sons, 2001: 103-121.
3. Percival SL, Thomas JG, Williams DW,. The world of microbiology and biofilmology. In:, Percival SL, Cutting K, editors. Microbiology of wounds. CRC Press, London, UK, 2010: 1-58.
4. Percival SL, Rogers AA,. The significance and role of biofilms in chronic wounds. In:, McBain A, Allison D, Pratten J, Spratt D, Upton M, Verran J, editors. Biofilms, persistence and ubiquity. Cardiff: Bioline, 2005: 171-180.
5. Percival SL, Kite P, Stickler D,. The use of urinary catheters and control of biofilms using TEDTA. Urol Res 2009; 37: 205-209.
6. Donlan RM, Costerton JW,. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193.
7. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG,. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 2002; 184: 1140-1154.
8. Percival SL, Walker JT,. Biofilms and public health significance. Biofouling 1999; 14: 99-115.
9. Percival SL, Kite P, Donlan RM,. Assessing the effectiveness of tetrasodium ethylenediaminetetraacetic acid as a novel central venous catheter (CVC) lock solution against biofilms using a laboratory model system. Infect Control Hosp Epidemiol 2005; 26: 515-519.
10. Kite P, Eastwood K, Sugden S, Percival SL,. Use of in-vivo generated biofilms from haemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in-vitro. J Clin Microbiol 2004; 42: 3073-3076.
11. Burmolle M, Thomsen TR, Fazli M, Dige I, Christensen L, Homøe P, Tvede M, Nyvad B, Tolker-Nielsen T, Givskov M, Moser C, Kirketerp-Møller K, Johansen HK, Høiby N, Jensen PO, Sørensen SO, Bjarnsholt T,. Biofilms in chronic infections-a matter of opportunity-monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol 2010; 59: 324-336.
12. Hooper S, Percival SL, Williams D,. Biofilms and implication in medical devices in humans and animals. In:, Percival SL, Cochrane C, Knottingbelt D, editors. Biofilms in veterinary medicine. London: Springer Press, Biofilm Series, 2011.
13. Percival SL, Kite P,. Catheters and infection control. J Vasc Access 2007; 2: 69-80.
14. Cooper R, Percival SL,. Human skin and microflora. In:, Percival SL, Cutting K, editors. Microbiology of wounds. CRC Press, London, UK, 2010: 58-82.
15. Woods E, Davis P, Barnett J, Percival SL,. Wound healing, immunology and biofilms. In:, Percival SL, Cutting K, editors. Microbiology of wounds. CRC Press, London, UK, 2010: 271-292.
16. Percival SL, Cooper R, Lipsky B,. Antimicrobial interventions for wounds. In:, Percival SL, Cutting K, editors. Microbiology of wounds. CRC Press, London, UK, 2010: 293-328.
17. Parsek MR, Singh PK,. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
18. Percival SL,. Ageing theories, diseases and microorganisms. In:, Percival SL, editor. Microbiology and aging: clinical manifestations. NY: Humana Press, 2008: 1-14.
19. Thomas JG, Percival SL,. Indigenous microbiota and association with the host. In:, Percival SL, editor. Microbiology and aging: clinical manifestations. NY: Humana Press, 2008: 15-38.
20. Percival SL, Emanuel C, Cutting KF, Williams DW,. Microbiology of skin and role of biofilms. Int Wound J 2011; 9: 14-32.
21. Wolcott R, Dowd S,. The role of biofilms: are we hitting the right target? Plast Reconstr Surg 2011; 127: 36S-37.
22. Percival SL, Bowler P,. The potential significance of biofilms in wounds. Wounds 2004; 16: 234-240.
23. Wolcott RD, Rhoads DD, Dowd SE,. Biofilms and chronic wound inflammation. J Wound Care 2008; 17: 333-341.
24. Bjarnsholt T, Kirketerp-Møller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Høiby N, Givskov M,. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008; 16: 2-10.
25. Singh VA, Barbul A,. Bacterial biofilms in wounds. Wound Repair Regen 2008; 16: 1.
26. Rhoads DD, Wolcott RD, Percival SL,. Biofilms in wounds: management strategies. J Wound Care 2008; 17: 502-508.
27. Black CE, Costerton JW,. Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. Surg Clin North Am 2010; 90: 1147-1160.
28. Cutting KC, Percival SL,. Biofilm management. Nurs Stand 2009; 23: 64-68.
29. Bonham PA,. Swab cultures for diagnosing wound infections: a literature review and clinical guideline. J Wound Ostomy Continence Nurs 2009; 36: 389-395.
30. Davies CE, Wilson MJ, Hill KE, Stephens P, Hill C, Harding KG, Thomas DW,. Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen 2001; 9: 332-340.
31. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS,. Biofilms in chronic wounds. Wounds Repair Regen 2008; 16: 37-44.
32. Davies CE, Hill KE, Newcombe RG, Stephens P, Wilson MJ, Harding KG, Thomas DW,. A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Repair Regen 2007; 15: 17-22.
33. Freeman K, Woods E, Welsby S, Percival SL, Cochrane CA,. Biofilm evidence and the microbial diversity of horse wounds. Can J Microbiol 2009; 55: 197-202.
34. Kanoe M, Hirabayashi T, Anzai T, Imagawa H, Tanaka Y,. Isolation of obligate anaerobic and some other bacteria from equine purulent lesions. Br Vet J 1988; 144: 374-378.
35. Orsini J, Elce Y, Kraus B,. Management of severely infected wounds in the equine patient. Equine Pract 2004; 3: 225-236.
36. Davies CE, Hill KE, Wilson MJ, Stephens P, Hill CM, Harding KG, Thomas DW,. Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and nonhealing chronic venous leg ulcers. J Clin Microbiol 2004; 42: 3549-3557.
37. Thomsen TR, Aasholm MS, Rudkjøbing VB, Saunders AM, Bjarnsholt T, Givskov M, Kirketerp-Møller K, Nielsen PH,. The bacteriology of chronic venous leg ulcer examined by culture-independent molecular methods. Wound Repair Regen 2010; 18: 38-49.
38. Holst H, Salling N, Andresen K, Christensen JJ, Kemp M,. Detection of anaerobic prosthetic joint infection by PCR and DNA sequencing-a case report. Acta Orthop 2008; 79: 568-570.
39. Neil KM, Axon JE, Todhunter PG, Adams PL, Caron JP, Adkins AR,. Septic osteitis of the distal phalanx in foals: 22 cases (1995-2002). J Am Vet Med Assoc 2007; 230: 1683-1690.
40. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, Hanna D, Ramage G,. Improved detection of infection in hip replacements: a currently underestimated problem. J Bone Joint Surg Br 1998; 80-B: 568-572.
41. Andersen A, Hill KE, Stephens P, Thomas DW, Jorgensen B, Krogfelt KA,. Bacterial profiling using skin grafting, standard culture and molecular bacteriological methods. J Wound Care 2007; 16: 171-175.
42. Dowd S, Sun Y, Secor P, Rhoads D, Wolcott B, James G, Wolcott R,. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008; 8: 43.
43. Sekiguchi H, Tomioka N, Nakahara T, Uchiyama H,. A single band does not always represent single bacterial strains in denaturing gradient gel electrophoresis analysis. Biotechnol Lett 2001; 23: 1205-1208.
44. Rosado AS, Duarte GF, Seldin L, Van Elsas JD,. Genetic diversity of nifH gene sequences in Paenibacillus azotofixans strains and soil samples analyzed by denaturing gradient gel electrophoresis of PCR-amplified gene fragments. Appl Environ Microbiol 1998; 64: 2770-2779.
45. Roth A, Fischer M, Hamid ME, Michalke S, Ludwig W, Mauch H,. Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J Clin Microbiol 1998; 36: 139-147.
46. Clarridge JE,. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 2004; 17: 840-862.
47. Wicker T, Narechania A, Sabot F, Stein J, Vu G, Graner A, Ware D, Stein N,. Low-pass shotgun sequencing of the barley genome facilitates rapid identification of genes, conserved non-coding sequences and novel repeats. BMC Genomics 2008; 9: 518.
48. Bjarnsholt T, Jensen PO, Burmolle M, Hentzer M, Haagensen JAJ, Hougen HP, Calum H, Madsen KG, Moser C, Molin S, Hoiby N, Givskov M,. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 2005; 151: 373-383.
49. Jensen PO, Bjarnsholt T, Rasmussen TB, Calum H, Moser C, Pressler T, Givskov M, Hoiby N,. Rapid necrotic killing of PMNs is caused by quorum sensing controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 2006; 3: 225-231.
50. Alhede M, Bjarnsholt T, Jensen PO, Phipps RK, Moser C, Christophersen L, Christensen LD, van, Gennip M, Parsek M, Hoiby N, Rasmussen TB, Givskov M,. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 2009; 155: 3500-3508.
51. Van Gennip M, Christensen LD, Alhede M, Phipps R, Jensen PO, Christophersen L, Pamp SJ, Moser C, Mikkelsen PJ, Koh AY, Tolker-Nielsen T, Pier GB, Hoiby N, Givskov M, Bjarnsholt T,. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS 2009; 117: 537-546.
52. Martin JM, Zenilman JM, Lazarus GS,. Molecular microbiology: a new dimension for cutaneous biology and wound healing. J Invest Dermatol 2010; 130: 38-48.
53. Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA,. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006; 3: 225-231.
54. Leake JL, Dowd SE, Wolcott RD, Zischkau AM,. Identification of yeast in chronic wounds using new pathogen-detection technologies. J Wound Care 2009; 18: 103-108.
55. Percival SL, Dowd S,. The microbiology of wounds. In:, Percival SL, Cutting K, editors. Microbiology of wounds. London: CRC Press, 2010: 187-218.
56. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D,. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS ONE 2008; 3: e3326.
57. Kirketerp-Møller K, Jensen PO, Fazli M, Madsen KG, Pedersen J, Moser C, Tolker-Nielsen T, Høiby N, Givskov M, Bjarnsholt T,. Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 2008; 46: 2717-2722.
58. Frank DN, Wysocki A, Specht-Glick DD, Rooney A, Feldman RA, St Amand AL, Pace NR, Trent JD,. Microbial diversity in chronic open wounds. Wound Repair Regen 2009; 17: 163-172.
59. Wolcott RD, Gontcharova V, Sun Y, Zischakau A, Dowd SE,. Bacterial diversity in surgical site infections: not just aerobic cocci any more. J Wound Care 2009; 18: 317-323.
60. Wolcott RD, Dowd SE,. A rapid method for characterising bacterial bioburden in chronic wounds. J Wound Care 2008; 17: 513-516.
61. Fisher TK, Wolcott R, Wolk DM, Bharara M, Kimbriel HR, Armstrong DG,. Diabetic foot infections: a need for innovative assessments. Int J Low Extrem Wounds 2010; 9: 31-36.
62. Gardner SE, Frantz RA, Doebbeling BN,. The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 2001; 9: 178-186.
63. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM,. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 2008; 16: 23-29.
64. Harrison-Baleastra C, Cazzaniga AL, Davis SC, Mertz PM,. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualised by light microscopy. Dermatol Surg 2003; 29: 631-635.
65. Mertz PM,. Cutaneous biofilms: friend or foe? Wounds 2003; 15: 129-132.
66. Akiyama H, Kanzaki H, Tada J, Arata J,. Staphylococcus aureus infection on cut wounds in the mouse skin: experimental staphylococcal botryomycosis. J Dermatol Sci 1996; 11: 234-238.
67. Serralta VW, Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM,. Lifestyles of bacteria in wounds: presence of biofilms? Wounds 2001; 13: 29-34.
68. Hill KE, Malic S, McKee R, Rennison T, Harding KG, Williams DW, Thomas DW,. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrob Chemother 2010; 65: 1195-1206.
69. Werthén M, Henriksson L, Jensen PO, Sternberg C, Givskov M, Bjarnsholt T,. An in vitro model of bacterial infections in wounds and other soft tissues. APMIS 2010; 118: 56-164.
70. Kanno E, Toriyabe S, Zhang L, Imai Y, Tachi M,. Biofilm formation on rat skin wounds by Pseudomonas aeruginosa carrying the green fluorescent protein gene. Exp Dermatol 2010; 19: 154-156.
71. Malic S, Hill KE, Hayes A, Percival SL, Thomas DW, Williams DW,. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology 2009; 155: 2603-2611.
72. Fazli M, Bjarnsholt T, Kirketerp-Moller K, Jorgensen B, Andersen AS, Krogfelt K, Givskov M, Tolker-Nielsen T,. Non-random distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol 2009; 47: 4084-4089.
73. Fadeev SB, Nemtseva NV,. Formation of biofilms by agents of surgical soft tissue infections. Zh Mikrobiol Epidemiol Immunobiol 2009; 4: 114-117.
74. Ista LK, Mendez S, Balamurugan SS, Balamurugan S, Rama RVG, Lopez GP,. Smart surfaces for the control of bacterial attachment and biofilm accumulation. In:, Provder T, Baghdachi J, editors. Smart coatings II. New York: American Chemical Society, 2009: 95-110.
75. Wakimoto N, Nishi J, Sheikh J, Nataro JP, Sarantuya JAV, Iwashita M, Manago K, Tokuda K, Yoshinaga M, Kawano Y,. Quantitative biofilm assay using a microtiter plate to screen for enteroaggregative Escherichia coli. Am J Trop Med Hyg 2004; 71: 687-690.
76. Hall-Stoodley L, Brun OS, Polshyna G, Barker LP,. Mycobacterium marinum biofilm formation reveals cording morphology. FEMS Microbiol Lett 2006; 257: 43-49.
77. Rupp ME, Fey PD,. In vivo models to evaluate adhesion and biofilm formation by Staphylococcus epidermidis. Methods Enzymol 2001; 336: 206-215.
78. Westgate SJ, Percival SL, Knottenbelt DC, Clegg PD, Cochrane CA,. Microbiology of equine wounds and evidence of bacterial biofilms. Vet Microbiol 2011; 150: 152-159.
79. Pearson MM, Hansen EJ,. Identification of gene products involved in biofilm production by Moraxella catarrhalis ETSU-9 in vitro. Infect Immun 2007; 75: 4316-4325.
80. Francois P, Vaudaux P, Foster TJ, Lew PD,. Host-bacteria interactions in foreign body infections. Infect Cont Hosp Ep 1996; 17: 514-520.
81. Mandlik A, Swierczynski A, Das A, Ton-That H,. Pili in Gram-positive bacteria: assembly, involvement in colonization and biofilm development. Trends Microbiol 2008; 16: 33-40.
82. Palmer RJ, Darveau R, Lamont RJ, Nyvad B, Teles RP,. Human oral bacterial biofilms: composition, dynamics, and pathogenesis. In:, Bjarnsholt T, Jensen PO, Moser C, Høiby N, editors. Biofilm infections. New York: Springer, 2011: 35-68.
83. Thorn RMS, Greenman J,. A novel in vitro flat-bed perfusion biofilm model for determining the potential antimicrobial efficacy of topical wound treatments. J Appl Microbiol 2009; 107: 2070-2079.
84. Thorn RM, Austin AJ, Greenman J, Wilkins JP, Davis PJ,. In vitro comparison of antimicrobial activity of iodine and silver dressings against biofilms. J Wound Care 2009; 18: 343-346.
85. Percival SL, Bowler P, Woods EJ,. Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen 2008; 16: 52-57.
86. Sun Y, Dowd SE, Smith E, Rhoads DD, Wolcott RD,. In vitro multispecies Lubbock chronic wound biofilm model. Wound Repair Regen 2008; 16: 805-813.
87. Dowd SE, Sun Y, Smith E, Kennedy JP, Jones CE, Wolcott R,. Effects of biofilm treatments on the multi-species Lubbock chronic wound biofilm model. J Wound Care 2009; 18: 508-512.
88. Sun Y, Smith E, Wolcott R, Dowd SE,. Propagation of anaerobic bacteria within an aerobic multi-species chronic wound biofilm model. J Wound Care 2009; 18: 426-431.
89. Davis SC, Mertz PM,. Determining the effect of an oak bark formulation on methicillin-resistant Staphylococcus aureus and wound healing in porcine wound models. Ostomy Wound Manage 2008; 54: 16-18.
90. Perez R, Davis SC,. Relevance of animal models for wound healing. Wounds 2008; 20: 3-8.
91. Zhao G, Hochwalt PC, Usui ML, Underwood RA, Singh PK, James GA, Stewart PS, Fleckman P, Olerud JE,. Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds. Wound Repair Regen 2010; 18: 467-477.
92. Schierle CF, De la Garza M, Mustoe TA, Galiano RD,. Staphylococcal biofilms impair wound healing by delaying re-epithelialization in a murine cutaneous wound model. Wound Repair Regen 2009; 17: 354-359.
93. Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, Griswold JA, Auer M, Hamood AN, Rumbaugh KP,. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 2007; 75: 3715-3721.
94. Stephens P, Wall IB, Wilson MJ, Hill KE, Davies CE, Hill CM, Harding KG, Thomas DW,. Anaerobic cocci populating the deep tissues of chronic wounds impair cellular wound healing responses in vitro. Br J Dermatol 2003; 148: 1-11.
95. Kirker KR, Secor PR, James GA, Fleckman P, Olerud JE, Stewart PS,. Loss of viability and induction of apoptosis in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair Regen 2009; 17: 690-699.
96. Wall I, Davies CE, Hill KE, Wilson MJ, Stephens P, Harding KG, Thomas DW,. Potential role of anaerobic cocci in impaired human wound healing. Wound Repair Regen 2002; 10: 346-353.
97. Charles CA, Ricotti CA, Davis SC, Mertz PM, Kirsner RS,. Use of tissue-engineered skin to study in vitro biofilm development. Dermatol Surg 2009; 35: 1334-1341.
98. Malic S, Hill KE, Ralphs JR, Hayes A, Thomas DW, Potts AJ, Williams DW,. Characterisation of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy. Oral Microbiol Immunol 2007; 22: 188-194.
99. Wolcott RD, Rumbaugh KP, James G, Schultz G, Phillips P, Yang Q, Watters C, Stewart PS, Dowd SE,. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care 2010; 19: 320-328.
100. Kennedy P, Brammah S, Wills E,. Burns, biofilm and a new appraisal of burn wound sepsis. Burns 2010; 36: 49-56.
101. Humphreys G, Lee GL, McBain AJ, Percival SL,. Assessment of combinatorial antimicrobial and anti-biofilm activities of ionic silver and sodium heaxametaphosphate against bacteria associated with chronic wounds. J Antimicrob Chemother 2011; 66: 2556-2561.
102. Bjarnsholt T, Kirketerp-Møller K, Kristiansen S, Phipps R, Nielsen AK, Jensen PO, Høiby N, Givskov M,. Silver against Pseudomonas aeruginosa biofilms. APMIS 2007; 115: 921-928.
103. Davis SC, Martinez L, Kirsner R,. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep 2006; 6: 439-445.
104. Wolcott RD, Kennedy JP, Dowd SE,. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care 2009; 18: 54-56.
105. Ammons CB,. Anti-biofilm strategies and the need for innovations in wound care. Recent Pat Antiinfect Drug Discov 2010; 5: 10-17.
106. Wolcott RD, Rhoads DD,. A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 2008; 17: 145-155.
107. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, Costerton JW, Dowd SE,. Chronic wounds and the medical biofilm paradigm. J Wound Care 2010; 19: 45-53.
108. Thomas S, Mccubbin P,. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care 2003; 12: 101-107.
109. Michaels JA, Campbell WB, King BM, Macintyre J, Palfreyman SJ, Shackley P, Stevenson MD,. A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial. Health Technol Assess 2009; 13: 1-114.
110. Percival SL, Hill KE, Malic S, Thomas DW, Williams DW,. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen 2011; 19: 1-9.
111. Kostenko V, Lyczak J, Turner K, Martinuzzi RJ,. Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Chemother 2010; 54: 5120-5131.
112. Bradshaw CE,. An in vitro comparison of the antimicrobial activity of honey, iodine and silver wound dressings. Biosci Horizons 2011; 4: 61-70.
113. Russell AD, Hugo WB,. Antimicrobial activity and action of silver. Prog Med Chem 1994; 31: 351-370.
114. Wolcott R, Cutting K, Dowd S, Percival SL,. Surgical site infections: biofilms, dehiscence and wound healing. US Dermatol Touch Briefings 2008; 56-59.
115. Percival SL, Slone W, Linton S, Okel T, Corum L, Thomas JG,. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates. Int Wound J 2011; 8: 237-243.
116. Percival SL, Thomas J, Linton S, Okel T, Corum L, Slone W,. The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds. Int Wound J 2011; Dec 19. doi: 10.1111/j.1742-481X.2011.00903.x. [Epub ahead of print].
117. Luo H, Wan K, Wang HH,. High-frequency conjugation system facilitates biofilm formation and pAM{beta}1 transmission by Lactococcus lactis. Appl Environ Microbiol 2005; 71: 2970-2978.
118. Blake M, Rotstein OD, Llano M, Girotti MJ, Reid G,. Aggregation by fragilis and non-fragilis Bacteroides strains in vitro. J Med Microbiol 1989; 28: 9-14.
119. Shirtliff ME, Peters BM, Jabra-Rizk MA,. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett 2009; 299: 1-8.
120. Percival SL, Bowler P,. Understanding the effects of bacterial communities and biofilms on wound healing. July, 2004. Available at http://www.worldwidewounds.com (accessed December 8, 2011).
121. Cooper R, Okhiria O,. Biofilms, wound infection and the issue of control. Wounds 2006; 2: 48-57.
122. Saye DE,. Recurring and antimicrobial-resistant infections: considering the potential role of biofilms in clinical practice. Ostomy Wound Manage 2007; 53: 46-52.
123. Percival SL, Cutting KF,. Biofilms: possible strategies for suppression in chronic wounds. Nurs Stand 2009; 23: 64, 66, 68 passim.
124. Rhoades D, Wolcott R, Curring K, Percival SL,. Biofilms and management in chronic infected wounds. In:, McBain A, Allison D, Pratten J, Spratt D, Upton M, Verran J, editors. Biofilms: coming of age. Cardiff: Bioline, 2007: 131-144.